Abstract
It is dangerous to take a position on the “state of the art” of thrombolytic therapy, particularly since a number of larger studies are being conducted and may be completed before this paper appears. The available data at the time of this meeting have convinced us that thrombolytic therapy is the preferred mode of treatment in a subgroup of patients with acute myocardial infarction: patients with extensive anterior myocardial ischemia or inferoposterior ischemia, who can be treated within 4–6 h after the onset of symptoms.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1: 397–402
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico (GISSI) (1987) Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 2: 871–874
Kennedy JW, Ritchie JL, Davis KB, Fritz JK (1985) Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: a 12-month follow-up report. N Engl J Med 312: 1073–1078
Simoons ML, Serruys PW, van den Brand M et al. (1985) Improved survival after early thrombolysis in acute myocardial infarction: a randomized trial by the Interuniversity Cardiology Institute in the Netherlands. Lancet 2: 578–582
Simoons ML, Serruys PW, van den Brand M et al. (1986) Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 7: 717–728
Serruys PW, Simoons ML, Suryapranata H et al. (1986) Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 729–742
Vermeer F, Simoons ML, Bär FW et al. (1986) Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation 74: 1379–1389
Vermeer F, Simoons ML, Zwaan C de etal. Cost benefit analysis of early thrombolytic therapy with intracoronary streptokinase. Br Heart J (in press)
Erbel R, Pop T, Henrichs KJ et al. (1986) Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. J Am Coll Cardiol 8: 485–495
Topol EJ, Califf RM, George BS etal., TAMI Study Group (1987) A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317: 581–588
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Simoons, M.L. (1989). Thrombolytic Therapy: State of the Art. In: Schmutzler, H., Rutsch, W., Dougherty, F.C. (eds) Limitation of Infarct Size. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73585-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-73585-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19148-3
Online ISBN: 978-3-642-73585-1
eBook Packages: Springer Book Archive